共 63 条
[1]
Tfelt-Hansen P(2009)Is there an inherent limit to the efficacy of calcitonin-gene related peptide receptor antagonists in acute migraine treatment? A comment J Headache Pain 350 1104-1110
[2]
Olesen J(2004)Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N Engl J Med 60 1259-1287
[3]
Diener HC(2000)Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy Drugs 372 2115-2123
[4]
Husstedt IW(2008)Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 70 1304-1312
[5]
Goadsby PJ(2008)Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Neurology 20 765-786
[6]
Hall D(2000)Guidelines for controlled trials of drugs in migraine, 2nd edn Cephalalgia 24 321-332
[7]
Meier U(2004)Double-blind clinical trials of oral triptans vs. other classes of acute migraine medication—a review Cephalalgia 23 775-780
[8]
Tfelt-Hansen P(2008)How strategies for managing patient visit time affect physician job satisfaction: a qualitative analysis J Gen Intern Med 47 475-479
[9]
De Vries P(2007)Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden Headache 47 355-363
[10]
Saxena PR(2007)Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study Headache 46 1261-1263